XML 23 R14.htm IDEA: XBRL DOCUMENT
v3.23.2

Note 8 - Accrued Expenses | 6 Months Ended
--- | ---
Jun. 30, 2023
Notes to Financial Statements |
Accounts Payable and Accrued Liabilities Disclosure [Text Block] |
8. | Accrued Expenses
Accrued expenses consist of the following:
|  | June 30, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Compensation and related expenses |  | $ | 8,690 |  |  | $ | 11,303 |
Professional fees |  |  | 2,802 |  |  |  | 3,145 |
Operating lease liability - current |  |  | 2,085 |  |  |  | 2,073 |
Clinical trial costs |  |  | 462 |  |  |  | 999 |
Income taxes payable |  |  | 931 |  |  |  | 810 |
Other |  |  | 542 |  |  |  | 510 |
Total |  | $ | 15,512 |  |  | $ | 18,840 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration